Clinical Trial Detail

Clinical Trials

Clinical Trial Detail

TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer

Complete title: TraceIT(TM) Hydrogel Tissue Marker for Patients Receiving Definitive Chemoradiation for Bladder Cancer

Research Study Number 9798
Principal Investigator Jing Zeng
Phase Pilot

Research Study Description

This pilot clinical trial studies how well TracelT hydrogel works in localizing bladder tumors in patients undergoing radiation therapy for bladder cancer. TracelT hydrogel marks the location of a bladder tumor and makes it more visible during imaging tests. Using TracelT hydrogel tissue marker may help doctors learn more about tumor location and altering radiation dosage for bladder cancer.

Eligibility Criteria (must meet the following to participate in this study)

Ages Eligible for Study: 18 Years and older (Adult, Senior)

Sexes Eligible for Study: All

- Histologically confirmed malignancy of the bladder

- No prior cystectomy

- Treatment plan for bladder must include at least 4 weeks of daily radiation treatment (most patients will receive chemotherapy concurrent with radiation, but this is not required for trial enrollment)

- Patient must undergo TraceIT hydrogel placement within 8 weeks prior to starting radiation therapy for bladder cancer

- Participants must have a complete history and physical examination within 60 days of study entry

- Participants must be able to provide informed consent for treatment and trial participation

- No restrictions on prior treatment to be eligible

Other eligibility criteria may apply.

Exclusions (conditions that would prevent participation in this study)

- Prior cystectomy

- Unable to have TraceIT hydrogel placement < 8 weeks prior to beginning radiation treatment

- Treatment for metastatic bladder cancer

Other exclusion criteria may apply.

Research Study Number 9798
Contact Jing Zeng
Telephone 206/598-4100

Keywords: Bladder Cancer; Solid Tumors; Urogenital Neoplasms; Urologic Neoplasms; Urinary Bladder Neoplasms

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials